LINC00698: A Long Intergenic Non-Protein-Coding RNA (G285401)

Target Name: LINC00698

NCBI ID: G285401

Other Name(s): long intergenic non-protein coding RNA 698 | Long intergenic non-protein coding RNA 698

LINC00698: A Long Intergenic Non-Protein-Coding RNA

Introduction

LINC00698 is a long non-coding RNA (lncRNA) that has been identified in various studies as having potential involvement in various biological processes. Its unique feature is its ability to interact with proteins, which has led to its potential as a drug target or biomarker . In this article, we will explore the research on LINC00698 and its potential applications in the medical field.

Structure and Expression

LINC00698 is a 22.9 kilobase (kb) RNA molecule. It is predominantly expressed in the brain and is also found in other tissues and cells. The RNA has a partial open reading frame (5'-end) and a partially introned exon (3' -end).

Expression of LINC00698

Studies have shown that LINC00698 is highly expressed in various tissues, including the brain, heart, and liver. It is also expressed in various cell types, including neurons, glial cells, and immune cells. The expression pattern of LINC00698 varies between different cell types and conditions.

Drug Interaction with LINC00698

LINC00698 has been shown to interact with various proteins, including the protein encoded by the gene SPAO2. The SPAO2 gene is associated with the development of various diseases, including neurodegenerative disorders, cardiovascular diseases, and cancer.

In addition to its interaction with SPAO2, LINC00698 has also been shown to interact with the protein encoded by the gene ZNF2. ZNF2 is associated with various diseases, including cancer, neurodegenerative disorders, and developmental defects.

Biomarker Potential

The potential use of LINC00698 as a biomarker is its ability to interact with various proteins, including SPAO2 and ZNF2. These proteins have been implicated in the development and progression of various diseases.

For example, LINC00698 has been shown to be highly expressed in individuals with neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. It has also been shown to interact with the protein encoded by the gene SNAP25, which is associated with the development of neurodegenerative disorders.

In addition to its potential as a biomarker, LINC00698 has also been shown to interact with the protein encoded by the gene HSP70, which is involved in various cellular processes, including stress response and DNA repair. This suggests that LINC00698 may be involved in the regulation of cellular processes that are relevant to neurodegenerative disorders.

The Potential for Development as a Drug Target

The potential use of LINC00698 as a drug target is based on its interaction with various proteins that are associated with the development and progression of various diseases.

For example, LINC00698 has been shown to interact with the protein encoded by the gene SPAO2, which is associated with the development of neurodegenerative disorders. The interaction between LINC00698 and SPAO2 may be involved in the regulation of cellular processes that are relevant to neurodegenerative disorders.

In addition to its interaction with SPAO2, LINC00698 has also been shown to interact with the protein encoded by the gene ZNF2, which is associated with various diseases, including cancer and neurodegenerative disorders. The interaction between LINC00698 and ZNF2 may be involved in the regulation of cellular processes that are relevant to these diseases.

Conclusion

In conclusion, LINC00698 is a long non-coding RNA that has been shown to interact with various proteins that are associated with the development and progression of various diseases. Its potential as a drug target or biomarker is based on its ability to interact with these proteins

Protein Name: Long Intergenic Non-protein Coding RNA 698

More Common Targets